Delivery Order SPE2DB22D2206-SPE2DB24FKK59

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,640.62 firm-fixed-price delivery order is for the supply of Prednisolone Acetate 0.12% Eye Drops, with a completion date of May 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $2,188.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565826826 - Prednisolone Acetate 1% Eye Drops, a medical product used to treat various eye conditions. The contract has a firm fixed price pricing type and an ultimate completion date of September 17, 2024. This appears to be a discrete delivery order under a larger Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564361827 - Prednisolone Acetate 1% Eye Drops in 10 ml containers. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,149.84 and a performance period through April 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a larger...
This federal contract award, valued at $10,337.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prednisolone AC 1% eye drops, a pharmaceutical product used in medical treatment. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prednisolone Acetate 1% eye drops. The $2,504.07 Firm Fixed Price delivery order contract has an ultimate completion date of September 6, 2024 and does not utilize any set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide this critical ophthalmic medication to support military treatment...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,859.72, is for the supply of prednisolone acetate 1% eye drops (10 ml) to support federal healthcare programs. The contract has a completion date of February 21, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Prednisolone Acetate 1% Eye Drops, 5 mL. The contract has a firm fixed price of $1,023.84 and a period of performance through August 8, 2024. This award is not associated with any set-aside program. As one of the largest pharmaceutical suppliers to the federal government, Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.92 delivery order contract is for the supply of Prednisolone Acetate 1% Eye Drops, a medication used to treat eye inflammation. The contract is a component of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Prednisolone Acetate 1% eye drops, a medication used to treat eye inflammation. The contract is a Delivery Order with a Firm Fixed Price type, valued at $2,030.68, and has an ultimate completion date of October 27, 2023. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Prednisolone Acetate 1% Eye Drops, a prescription ophthalmic medication. The $6,747.26 firm fixed-price delivery order was placed against an existing Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a comprehensive range...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKK59
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,953.57 Firm Fixed Price delivery order is for the supply of 4565844506 - Prednisolone Acetate 1% Eye Drops, 10 mL. The contract has a completion date of September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/17/24, 9:14 AM